NRx Pharmaceuticals Statistics Share Statistics NRx Pharmaceuticals has n/a
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding n/a Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) 0.67% Shares Floating n/a Failed to Deliver (FTD) Shares 103 FTD / Avg. Volume 0.75%
Short Selling Information The latest short interest is 1.78K, so 0% of the outstanding
shares have been sold short.
Short Interest 1.78K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.92 and the forward
PE ratio is null.
NRx Pharmaceuticals's PEG ratio is
0.02.
PE Ratio -0.92 Forward PE n/a PS Ratio 0 Forward PS 0 PB Ratio -1 P/FCF Ratio -2.18 PEG Ratio 0.02
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for NRx Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.15,
with a Debt / Equity ratio of -0.28.
Current Ratio 0.15 Quick Ratio 0.15 Debt / Equity -0.28 Debt / EBITDA -0.36 Debt / FCF -0.62 Interest Coverage -80.44
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee n/a Employee Count undefined Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 33.33% in the
last 52 weeks. The beta is 1.55, so NRx Pharmaceuticals's
price volatility has been higher than the market average.
Beta 1.55 52-Week Price Change 33.33% 50-Day Moving Average 0.08 200-Day Moving Average 0.1 Relative Strength Index (RSI) 54.54 Average Volume (20 Days) 13,728
Income Statement
Revenue n/a Gross Profit n/a Operating Income -18.5M Net Income -25.13M EBITDA -18.5M EBIT -24.9M Earnings Per Share (EPS) -2.39
Full Income Statement Balance Sheet The company has 1.44M in cash and 6.58M in
debt, giving a net cash position of -5.13M.
Cash & Cash Equivalents 1.44M Total Debt 6.58M Net Cash -5.13M Retained Earnings -278.27M Total Assets 7.59M Working Capital -25.5M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -10.64M
and capital expenditures 0, giving a free cash flow of -10.64M.
Operating Cash Flow -10.64M Capital Expenditures n/a Free Cash Flow -10.64M FCF Per Share -1.01
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
